missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18676083

ICOS Antibody (2317C) [Allophycocyanin], Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals FAB1682A

448.80 EUR valid until 2025-12-16
BEST PRICE on Promo! Use promo code "24090" to get your promotional price.

Product Code. 18676083

  • 520.00€ / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ICOS Monoclonal antibody specifically detects ICOS in Mouse samples. It is validated for Flow Cytometry, Blockade of Receptor-ligand Interaction, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ICOS
Monoclonal
APC
PBS
Rabbit
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Mouse
Purified
Flow Cytometry, Blockade of Receptor-ligand Interaction, CyTOF
2317C
Flow Cytometry, Blockade of Receptor-ligand Interaction, CyTOF-ready
Activation-inducible lymphocyte immunomediatory molecule, AILIMCD278, CD278 antigen, CVID1, inducible costimulator, inducible T-cell costimulator, inducible T-cell co-stimulator, MGC39850
Chinese Hamster Ovary cell line, CHO-derived mouse ICOS, Met1-Leu142, Accession # Q9WVS0
0.1 mL
Adaptive Immunity, Immunology
29851
Store at 4°C in the dark.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.